Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001475030-16-000002
Filing Date
2016-07-14
Accepted
2016-07-14 10:33:26
Documents
1
Effectiveness Date
2016-07-14
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 10865
  Complete submission text file 0001475030-16-000002.txt   11877
Mailing Address 8 PENN CENTER PHILADELPHIA PA 19103
Business Address 8 PENN CENTER PHILADELPHIA PA 19103 267-273-7940
Tarsa Therapeutics, Inc. (Filer) CIK: 0001475030 (see all company filings)

EIN.: 264828302 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-266953 | Film No.: 161766803